Evidence Hub

Formulation and In-Vitro Evaluation of Tadalafil Oral Disintegrating Strips for Enhanced Bioavailability

Nabanita Bijoy Das, Hadeel Hassan Mohieldien Fadlelmawla

International journal of pharmaceutical research and applications, 2025

Abstract

Background: Erectile dysfunction (ED) is a

prevalent disorder affecting men worldwide, often

managed with oral phosphodiesterase type-5

(PDE5) inhibitors such as tadalafil. However, its

limited oral bioavailability (~28%) necessitates the

exploration of novel dosage forms. Oral

disintegrating strips (ODS) provide a promising

alternative due to rapid disintegration, improved

patient compliance, and avoidance of first-pass

metabolism.

Aim: To formulate and evaluate tadalafil oral

disintegrating strips (ODS) using solvent casting

method for enhanced dissolution and

bioavailability.

Methods: Six formulations (F1–F6) were prepared

using hydroxypropyl methylcellulose (HPMC K15) as film-forming agent, glycerol as plasticizer,

Tween 80 and sodium lauryl sulphate (SLS) as

surfactants, citric acid as saliva stimulator, and

sucrose with vanillin as sweetening/flavoring

agents. The strips were evaluated for thickness,

folding endurance, weight variation, drug content,

disintegration time, in-vitro dissolution, and

stability as per ICH guidelines. Drug–excipient

compatibility was assessed via FT-IR.

Results: Among all formulations, F4 demonstrated

superior performance with 92.83% drug content,

disintegration time <30 seconds, and 94.2%

cumulative drug release within 30 minutes. FT-IR

spectra confirmed no significant drug–excipient

interactions. Stability studies at 40±2°C/75% RH

for 2 months showed no major changes in

physicochemical parameters.

Conclusion: Tadalafil ODS prepared by…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free